Premier Alternatives

DesiCorp

Louisville, KY · Founded 2017 · Privately Held (backing)

Developer of a freeze-dried red blood cell technology designed to offer a proper method to extend the shelf-life of blood. DesiCorp is based in Louisville, KY and was founded in 2017. It was valued at $30.1 million at its seed round in Apr 2026, the last priced event on record. It has raised $6 million across 2 recorded rounds; the latest was a $3.5 million seed round in Mar 2026.

PMV mark · valuation
$30.1M
Oct 2026
Priced at
its seed round
Apr 2026
Total raised
$6.0M
Last round
Seed Round
Mar 2026

DesiCorp key facts

as of Oct 2026
  • Developer of a freeze-dried red blood cell technology designed to offer a proper method to extend the shelf-life of blood.
  • DesiCorp is valued at approximately $30.1M as of Oct 2026, set at its seed round, Apr 2026; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $6.0M across 2 recorded rounds; the latest was Seed Round ($3.5M) in Mar 2026.
  • Notable investors include US National Science Foundation, United States Department of War, National Institutes of Health, Keyhorse Capital, Kentucky Innovation Network — 8 tracked in total.
  • DesiCorp has filed 2 Form Ds with the SEC since 2024, most recently Nov 2025 ($4.2M sold to 15 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
MEDIUM confidence
$30.1M

Valued at $30.1M at its seed round, Apr 2026. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of DesiCorp with a free account
  • ·Watch DesiCorp: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

DesiCorp funding rounds

2 rounds
Mar 2026Seed Round$3.5MSEC filing▮
Jul 2024Early Stage VC$5.2MSEC filing▮
Full funding history →

DesiCorp valuation

DesiCorp was valued at $30.1 million at its seed round in Apr 2026. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has DesiCorp raised?

DesiCorp has raised $6 million across 2 recorded rounds since 2024. The largest was a $5.2 million early-stage round in Jul 2024; the most recent was a $3.5 million seed round in Mar 2026.

DesiCorp has filed 2 Form Ds with the SEC since 2024, most recently in Nov 2025 ($4.2 million sold to 15 investors).

DesiCorp investors

8 investors are on record for DesiCorp, including US National Science Foundation, United States Department of War, National Institutes of Health and Keyhorse Capital. The seed round in Mar 2026 drew 12 investors.

About DesiCorp

Developer of a freeze-dried red blood cell technology designed to offer a proper method to extend the shelf-life of blood. The company provides a powder for applications in disaster relief situations, battlefield settings, and remote rural emergency rescue situations, enabling medical practitioners to have blood for transfusions in case of limited supply and in places where it is difficult to store due to the limited availability of refrigeration.

Sector
Healthcare
HQ
Louisville, KY, United States
Founded
2017
Employees
9
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.